Annual report
4323.TEDINET S100R5Y8
Period2022-04-01 → 2023-03-31
Filed2023-06-29
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 150
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥23.5bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥21.4bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales |
| Revenue | ¥18.8bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥18.0bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥16.9bn | 2018-04-01 → 2019-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | ¥2.4bn | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Operating income | ¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Operating income |
| Ordinary income | ¥2.5bn | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.1bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥1.3bn | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.0bn | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥867m | 2018-04-01 → 2019-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.5bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥2.0bn | 2021-04-01 → 2022-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥579m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥31m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥318m | 2018-04-01 → 2019-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥1.8bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss |
| Total assets | ¥17.4bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥15.5bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥12.9bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥13.0bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥13.6bn | at 2019-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥6.6bn | at 2023-03-31 | Cons. | Liabilities |
| Total liabilities | ¥6.3bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.8bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥9.2bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.9bn | at 2021-03-31d | Cons. | Net assets |
| Net assets / equity | ¥6.2bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥6.4bn | at 2019-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.2bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.8bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.5bn | at 2022-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥4.9bn | at 2021-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.9bn | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥4.2bn | at 2019-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.2bn | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥2.1bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥417m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥542m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥81m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | ¥87m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥527m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.1bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥281m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥487m | 2021-04-01 → 2022-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.2bn | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥185m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥1.2bn | 2018-04-01 → 2019-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥144.5 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥112.32 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥53.98 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-2.88 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.29 | 2018-04-01 → 2019-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥53.95 | 2020-04-01 → 2021-03-31d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥878.07 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥746.86 | at 2022-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥632.98 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥577.03 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥601.17 | at 2019-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 61.8% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.9% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.0% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.7% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.8% | at 2019-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 17.8% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 16.7% | 2021-04-01 → 2022-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.9% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | -0.5% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 5.1% | 2018-04-01 → 2019-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,687 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 1,448 | at 2022-03-31 | Cons. | Number of employees |
| Employees | 1,320 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 1,164 | at 2020-03-31d | Cons. | Number of employees |
| Employees | 1,111 | at 2019-03-31d | Cons. | Number of employees |
| Revenue | ¥18.6bn | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥17.1bn | 2021-04-01 → 2022-03-31 | Standalone | Net sales |
| Revenue | ¥15.2bn | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥14.4bn | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥13.8bn | 2018-04-01 → 2019-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥1.8bn | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Operating income | ¥1.6bn | 2021-04-01 → 2022-03-31 | Standalone | Operating income |
| Ordinary income | ¥2.1bn | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.8bn | 2021-04-01 → 2022-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥1.1bn | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.1bn | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥780m | 2018-04-01 → 2019-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.1bn | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Profit before tax | ¥1.5bn | 2021-04-01 → 2022-03-31 | Standalone | Income before income taxes |
| Net income | ¥1.6bn | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥1000m | 2021-04-01 → 2022-03-31 | Standalone | Profit loss |
| Net income | ¥401m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥22m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥330m | 2018-04-01 → 2019-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥15.5bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥14.0bn | at 2022-03-31 | Standalone | Assets |
| Total assets | ¥11.8bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥12.1bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥12.4bn | at 2019-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥5.3bn | at 2023-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.2bn | at 2022-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥10.2bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥8.8bn | at 2022-03-31 | Standalone | Net assets |
| Net assets / equity | ¥6.9bn | at 2021-03-31d | Standalone | Net assets |
| Net assets / equity | ¥6.5bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥6.6bn | at 2019-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥4.9bn | at 2023-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥4.2bn | at 2022-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥132.94 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥84.39 | 2021-04-01 → 2022-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥37.41 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.03 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥31.48 | 2018-04-01 → 2019-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥37.4 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥32 | 2022-04-01 → 2023-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥40 | 2021-04-01 → 2022-03-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥28 | 2020-04-01 → 2021-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥28 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥28 | 2018-04-01 → 2019-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥831.86 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥717.93 | at 2022-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥640.31 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥609.7 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥621.41 | at 2019-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 65.8% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 63.0% | at 2022-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 58.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.0% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 53.0% | at 2019-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 17.2% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 12.7% | 2021-04-01 → 2022-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.3% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.1% | 2018-04-01 → 2019-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 12,418,460 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 6,209,230 | at 2022-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,612,230 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,612,230 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 5,612,230 | at 2019-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 926 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 871 | at 2022-03-31 | Standalone | Number of employees |
| Employees | 827 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 753 | at 2020-03-31d | Standalone | Number of employees |
| Employees | 712 | at 2019-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 67
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2023-03-31 | −¥182m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2023-03-31 | −¥182m |
| Reconciling Itemsreconciling | segment assets | at 2023-03-31 | ¥2.0bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2023-03-31 | −¥1.7bn |
| Global Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥32m |
| Global Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥54m |
| Global Businessreportable segment | employees | at 2023-03-31 | 587 pure |
| Global Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥2.7bn |
| Global Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥2.7bn |
| Global Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥50m |
| Global Businessreportable segment | segment assets | at 2023-03-31 | ¥2.1bn |
| Global Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥271m |
| Medical Big Data Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥30m |
| Medical Big Data Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥19m |
| Medical Big Data Businessreportable segment | employees | at 2023-03-31 | 107 pure |
| Medical Big Data Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| Medical Big Data Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥2.0bn |
| Medical Big Data Businessreportable segment | segment assets | at 2023-03-31 | ¥1.6bn |
| Medical Big Data Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥457m |
| Package Businessreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥19m |
| Package Businessreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥28m |
| Package Businessreportable segment | employees | at 2023-03-31 | 206 pure |
| Package Businessreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥4.5bn |
| Package Businessreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥4.5bn |
| Package Businessreportable segment | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥42m |
| Package Businessreportable segment | segment assets | at 2023-03-31 | ¥3.6bn |
| Package Businessreportable segment | segment profit | 2022-04-01 → 2023-03-31 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2022-04-01 → 2023-03-31 | ¥123m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2022-04-01 → 2023-03-31 | ¥163m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2023-03-31 | ¥23.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2023-03-31 | ¥23.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2023-03-31 | ¥182m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2023-03-31 | ¥15.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2023-03-31 | ¥4.1bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2022-03-31 | −¥94m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2022-03-31 | −¥94m |
| Reconciling Itemsreconciling | segment assets | at 2022-03-31 | ¥1.8bn |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2022-03-31 | −¥1.5bn |
| Global Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥40m |
| Global Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥60m |
| Global Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥2.1bn |
| Global Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥2.1bn |
| Global Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥16m |
| Global Businessreportable segment | segment assets | at 2022-03-31 | ¥1.9bn |
| Global Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥49m |
| Medical Big Data Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥13m |
| Medical Big Data Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥16m |
| Medical Big Data Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥1.8bn |
| Medical Big Data Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥1.8bn |
| Medical Big Data Businessreportable segment | segment assets | at 2022-03-31 | ¥1.2bn |
| Medical Big Data Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥381m |
| Package Businessreportable segment | capex | 2021-04-01 → 2022-03-31 | ¥23m |
| Package Businessreportable segment | depreciation | 2021-04-01 → 2022-03-31 | ¥28m |
| Package Businessreportable segment | revenue | 2021-04-01 → 2022-03-31 | ¥4.6bn |
| Package Businessreportable segment | revenue external | 2021-04-01 → 2022-03-31 | ¥4.6bn |
| Package Businessreportable segment | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥6m |
| Package Businessreportable segment | segment assets | at 2022-03-31 | ¥3.3bn |
| Package Businessreportable segment | segment profit | 2021-04-01 → 2022-03-31 | ¥1.5bn |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-04-01 → 2022-03-31 | ¥112m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-04-01 → 2022-03-31 | ¥161m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2022-03-31 | ¥21.5bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2022-03-31 | ¥21.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2022-03-31 | ¥94m |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-03-31 | ¥13.8bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2022-03-31 | ¥3.5bn |
| Medical Big Data Businessreportable segment | employees | at 2023-03-31 | 82 pure |
| Package Businessreportable segment | employees | at 2023-03-31 | 200 pure |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,639
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 3908254000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 4853695000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 6463823000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentYearInstant | 6793050000 | JPY |
| Number of employees | Prior4YearInstant | 1111 | |
| Number of employees | Prior3YearInstant | 1164 | |
| Number of employees | Prior2YearInstant | 1320 | |
| Number of employees | Prior1YearInstant | 1448 | |
| Number of employees | CurrentYearInstant | 1687 | |
| Net sales (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 13796908000 | JPY |
| Net sales (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 14427659000 | JPY |
| Net sales (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 15203765000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 17082806000 | JPY |
| Net sales (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 18552222000 | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 779590000 | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 1121163000 | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 1106164000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 1751066000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 2134219000 | JPY |
| Net income loss (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 330491000 | JPY |
| Net income loss (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 21658000 | JPY |
| Net income loss (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 401246000 | JPY |
| Net income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 999643000 | JPY |
| Net income loss (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 1630462000 | JPY |
| Capital stock (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 1076669000 | JPY |
| Capital stock (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 1076669000 | JPY |
| Capital stock (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 1076669000 | JPY |
| Capital stock (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 1535409000 | JPY |
| Capital stock (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 1535409000 | JPY |
| Total number of issued shares (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 5612230 | |
| Total number of issued shares (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 5612230 | |
| Total number of issued shares (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 5612230 | |
| Total number of issued shares (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 6209230 | |
| Total number of issued shares (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 12418460 | |
| Net assets (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 6596273000 | JPY |
| Net assets (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 6539989000 | JPY |
| Net assets (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 6897566000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 8805037000 | JPY |
| Net assets (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 10202132000 | JPY |
| Total assets (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 12439142000 | JPY |
| Total assets (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 12109632000 | JPY |
| Total assets (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 11785585000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 13974559000 | JPY |
| Total assets (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 15504289000 | JPY |
| Net assets per share (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 621.41 | |
| Net assets per share (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 609.70 | |
| Net assets per share (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 640.31 | |
| Net assets per share (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 717.93 | |
| Net assets per share (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 831.86 | |
| Dividend paid per share (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 28.00 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |